Skip to content

Nature experience-based virtual reality improves depressive symptoms in a young population: A pilot study

Development of a virtual reality-based meditation program for depression improvement and evaluation of effectiveness through clinical trials.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009142
Enrollment
40
Registered
2024-01-30
Start date
2023-05-18
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(virtual reality device) : Intervention group 1: The experimental group will watch the natural experience-based VR video developed in this study, stored on the HMD, and take the HMD home to watc

Sponsors

Jungwon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria were no history of previous diagnosis, no depression treatment of any type, score higher than 14 on the Korean version of the Beck Depression Inventory (K-BDI)-II, and age between 20 and 50 years.

Exclusion criteria

Exclusion criteria: Exclusion criteria were age under 20 years; heavy alcohol use; history of seizures or epilepsy in VR; or use of devices such as a pacemaker, hearing aids, or defibrillator. Subjects older than 50 years were excluded because they are more susceptible to VR sickness than younger users. People who have experienced undesirable symptoms, such dizziness or headaches, when using an HMD with VR technology were also excluded.

Design outcomes

Primary

MeasureTime frame
Development of a virtual reality-based meditation program for depression improvement and evaluation of effectiveness through clinical trials.

Secondary

MeasureTime frame
Differences between Korean Beck Depression Inventory (K-BDI)-II questionnaires administered before and after starting VR viewing;Differences in levels of free brain-derived neurotrophic factor (BDNF), cortisol, and interleukin-6 (IL-6) measured before and after starting VR viewing. ?

Countries

Korea, Republic of

Contacts

Public ContactDae-Wui Yoon

Jungwon University

ydw@jwu.ac.kr+82-43-830-8863

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026